Rossby Financial LCC Increases Holdings in Cardinal Health, Inc. $CAH

Rossby Financial LCC grew its holdings in shares of Cardinal Health, Inc. (NYSE:CAH) by 205.9% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 520 shares of the company’s stock after buying an additional 350 shares during the period. Rossby Financial LCC’s holdings in Cardinal Health were worth $87,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors also recently bought and sold shares of the company. Greykasell Wealth Strategies Inc. acquired a new stake in shares of Cardinal Health during the first quarter worth about $26,000. Jones Financial Companies Lllp increased its position in shares of Cardinal Health by 198.3% during the first quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock worth $27,000 after purchasing an additional 14,034 shares in the last quarter. Atlantic Edge Private Wealth Management LLC increased its position in shares of Cardinal Health by 75.0% during the second quarter. Atlantic Edge Private Wealth Management LLC now owns 175 shares of the company’s stock worth $29,000 after purchasing an additional 75 shares in the last quarter. GW&K Investment Management LLC increased its position in shares of Cardinal Health by 113.4% during the first quarter. GW&K Investment Management LLC now owns 271 shares of the company’s stock worth $37,000 after purchasing an additional 144 shares in the last quarter. Finally, Harbor Asset Planning Inc. acquired a new stake in shares of Cardinal Health during the second quarter worth about $49,000. 87.17% of the stock is owned by hedge funds and other institutional investors.

Cardinal Health Stock Up 1.1%

CAH stock opened at $164.59 on Thursday. The company has a market cap of $39.10 billion, a price-to-earnings ratio of 25.52, a PEG ratio of 1.38 and a beta of 0.71. The business has a fifty day simple moving average of $153.56 and a 200-day simple moving average of $153.73. Cardinal Health, Inc. has a 52 week low of $106.98 and a 52 week high of $168.44.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings results on Tuesday, August 12th. The company reported $2.08 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.03 by $0.05. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.The firm had revenue of $60.16 billion during the quarter, compared to the consensus estimate of $60.91 billion. During the same period in the prior year, the firm earned $1.84 EPS. The firm’s quarterly revenue was up .5% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. As a group, analysts expect that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, October 15th. Shareholders of record on Wednesday, October 1st were paid a dividend of $0.5107 per share. The ex-dividend date was Wednesday, October 1st. This represents a $2.04 annualized dividend and a yield of 1.2%. Cardinal Health’s dividend payout ratio is presently 31.63%.

Insider Activity

In other Cardinal Health news, insider Jessica L. Mayer sold 38,078 shares of the company’s stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total transaction of $5,666,767.96. Following the sale, the insider owned 48,457 shares in the company, valued at $7,211,370.74. This represents a 44.00% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, CEO Jason M. Hollar sold 35,901 shares of the company’s stock in a transaction that occurred on Wednesday, August 20th. The shares were sold at an average price of $150.04, for a total value of $5,386,586.04. Following the sale, the chief executive officer owned 200,000 shares in the company, valued at $30,008,000. The trade was a 15.22% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 271,676 shares of company stock valued at $40,489,525 over the last three months. Company insiders own 0.12% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on CAH. Morgan Stanley restated an “overweight” rating on shares of Cardinal Health in a research report on Tuesday, August 12th. Argus set a $189.00 price objective on Cardinal Health in a report on Friday, August 22nd. UBS Group reaffirmed a “buy” rating on shares of Cardinal Health in a report on Tuesday, August 12th. Robert W. Baird lifted their price objective on Cardinal Health from $197.00 to $203.00 and gave the company an “outperform” rating in a report on Wednesday, August 13th. Finally, Wall Street Zen lowered Cardinal Health from a “strong-buy” rating to a “buy” rating in a report on Saturday, August 2nd. Twelve investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $166.00.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.